Nkarta to Participate in November Investor Conferences
Thursday, October 30, 2025 1 min read
Key Takeaway: Nkarta, Inc. has announced its participation in two upcoming investor conferences in November 2025. The events include a fireside chat at the Stifel 2025 Healthcare Conference on November 12 and another at TD Cowen’s Immunology & Inflammation Summit on November 13. A webcast of these events will be available on their website.
Price reaction · baseline $2.095 (2025-10-30T17:13:00.000Z) · hit during market hours · clean, no other NKTX news in the window
day 0 close · peak
-0.7%
Market Sentiment Analysis
POSITIVE FACTORS
Nkarta is actively engaging with investors through multiple conferences.
The company is advancing innovative NK cell therapies.
Webcasts of the events will be accessible for broader audience engagement.
Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences next month:
A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website,www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website atwww.nkartatx.com.